We’re proud to share that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, will be presenting at the 4th World ADC Asia Summit, taking place June 10–12 in Incheon, South Korea. Dr. Chu will share updates on our innovative tech platforms and drug candidates, with a special focus on our ADC technologies. He will present … Continue reading Join our presentation at the World ADC Asia 2025 Conference